| Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy VLJL Thijssen, R Postel, RJ Brandwijk, RPM Dings, I Nesmelova, S Satijn, ... Proceedings of the National Academy of Sciences 103 (43), 15975-15980, 2006 | 581 | 2006 |
| Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice RR Koenen, P Von Hundelshausen, IV Nesmelova, A Zernecke, EA Liehn, ... Nature medicine 15 (1), 97-103, 2009 | 497 | 2009 |
| Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization RPM Dings, M Loren, H Heun, E McNiel, AW Griffioen, KH Mayo, ... Clinical Cancer Research 13 (11), 3395-3402, 2007 | 339 | 2007 |
| Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature JR Van Beijnum, RP Dings, E Van Der Linden, BMM Zwaans, ... Blood 108 (7), 2339-2348, 2006 | 305 | 2006 |
| Motional model analyses of protein and peptide dynamics using 13C and 15N NMR relaxation VA Daragan, KH Mayo Progress in Nuclear Magnetic Resonance Spectroscopy 31 (1), 63-105, 1997 | 300 | 1997 |
| Anti‐angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte‐endothelium interactions and infiltration in tumors AEM Dirkx, MGA Egbrink, K Castermans, DWJ Van Der Schaft, ... The FASEB Journal 20 (6), 621-630, 2006 | 274 | 2006 |
| Chemokines from a structural perspective MC Miller, KH Mayo International journal of molecular sciences 18 (10), 2088, 2017 | 245 | 2017 |
| Anginex, a designed peptide that inhibits angiogenesis AW GRIFFIOEN, DWJ VAN DER SCHAFT, AF BARENDSZ-JANSON, ... Biochemical Journal 354 (2), 233-242, 2001 | 206 | 2001 |
| Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications DMEI Hellebrekers, K Castermans, E Viré, RPM Dings, NTH Hoebers, ... Cancer research 66 (22), 10770-10777, 2006 | 163 | 2006 |
| Synergistic Targeting of αvβ3 Integrin and Galectin-1 with Heteromultivalent Paramagnetic Liposomes for Combined MR Imaging and Treatment of Angiogenesis E Kluza, DWJ Van Der Schaft, PAI Hautvast, WJM Mulder, KH Mayo, ... Nano letters 10 (1), 52-58, 2010 | 158 | 2010 |
| Structure and dynamics of peptide− amphiphiles incorporating triple-helical proteinlike molecular architecture YC Yu, V Roontga, VA Daragan, KH Mayo, M Tirrell, GB Fields Biochemistry 38 (5), 1659-1668, 1999 | 153 | 1999 |
| Promotion of peptide antimicrobial activity by fatty acid conjugation AF Chu-Kung, KN Bozzelli, NA Lockwood, JR Haseman, KH Mayo, ... Bioconjugate chemistry 15 (3), 530-535, 2004 | 151 | 2004 |
| Eosinophil peroxidase oxidation of thiocyanate: characterization of major reaction products and a potential sulfhydryl-targeted cytotoxicity system M Arlandson, T Decker, VA Roongta, L Bonilla, KH Mayo, JC MacPherson, ... Journal of Biological Chemistry 276 (1), 215-224, 2001 | 150 | 2001 |
| Platelet factor 4 promotes adhesion of hematopoietic progenitor cells and binds IL-8: novel mechanisms for modulation of hematopoiesis AZ Dudek, I Nesmelova, K Mayo, CM Verfaillie, S Pitchford, A Slungaard Blood 101 (12), 4687-4694, 2003 | 145 | 2003 |
| Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: arginine residues are crucial for binding KH Mayo, E Ilyina, V Roongta, M Dundas, J Joseph, CK Lai, T Maione, ... Biochemical Journal 312 (2), 357-365, 1995 | 145 | 1995 |
| Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation P Von Hundelshausen, SM Agten, V Eckardt, X Blanchet, MM Schmitt, ... Science translational medicine 9 (384), eaah6650, 2017 | 141 | 2017 |
| Antitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding RPM Dings, MC Miller, I Nesmelova, L Astorgues-Xerri, N Kumar, ... Journal of medicinal chemistry 55 (11), 5121-5129, 2012 | 134 | 2012 |
| Human platelet factor 4 monomer-dimer-tetramer equilibria investigated by proton NMR spectroscopy KH Mayo, MJ Chen Biochemistry 28 (24), 9469-9478, 1989 | 133 | 1989 |
| The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin RPM Dings, Y Yokoyama, S Ramakrishnan, AW Griffioen, KH Mayo Cancer research 63 (2), 382-385, 2003 | 128 | 2003 |
| Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells DWJ Van Der Schaft, EAH Toebes, JR Haseman, KH Mayo, AW Griffioen Blood, The Journal of the American Society of Hematology 96 (1), 176-181, 2000 | 127 | 2000 |
